FindTrial
Sign In

TAK-901

DRUG2 trials

Sponsors

Millennium Pharmaceuticals, Inc.

Conditions

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAdvanced PolycythemiaAdvanced Solid TumorsChronic Lymphocytic LeukemiaChronic Myelogenous LeukemiaLymphomaMultiple Myeloma

Phase 1

A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies
CompletedNCT00807677
Millennium Pharmaceuticals, Inc.Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Advanced Polycythemia +9
Start: 2009-03-31End: 2013-03-31Updated: 2013-07-02
Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma
CompletedNCT00935844
Millennium Pharmaceuticals, Inc.Advanced Solid Tumors, Lymphoma
Start: 2009-10-31End: 2011-11-30Updated: 2011-12-08